We are live on
!
Find out more
HCMNY
Howard Capital Management (New York) Portfolio holdings
AUM
$891M
1-Year Est. Return
34.82%
This Fund
S&P 500
This Quarter
Est. Return
-13.93%
1 Year Est. Return
+34.82%
3 Year Est. Return
+76.77%
5 Year Est. Return
+136.83%
10 Year Est. Return
–
AUM
$606M
AUM Growth
-$144M
(-19%)
Cap. Flow
-$30.3M
Cap. Flow
% of AUM
-5%
Top 10 Holdings %
Top 10 Hldgs %
37.5%
Holding
117
New
4
Increased
16
Reduced
54
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$12.4M |
| 2 |
iShares US Medical Devices ETF
IHI
|
+$339K |
| 3 |
International Flavors & Fragrances
IFF
|
+$322K |
| 4 |
FRC.PRH
First Republic Bank
FRC.PRH
|
+$274K |
| 5 |
Cigna
CI
|
+$265K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$8.23M |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$5.85M |
| 3 |
Cummins
CMI
|
+$5.12M |
| 4 |
Vulcan Materials
VMC
|
+$4.84M |
| 5 |
Conagra Brands
CAG
|
+$4.43M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.62% |
| 2 | Healthcare | 13.86% |
| 3 | Communication Services | 10.72% |
| 4 | Financials | 10.28% |
| 5 | Industrials | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$3.45T
| $32.2M | 5.32% |
316,938
-4,484
| -1% | -$480K |
|
2
State Street SPDR S&P 500 ETF Trust
SPY
$795B
| $30.6M | 5.05% |
122,238
+387
| +0.3% | +$104K |
|
3
Amazon
AMZN
$2.92T
| $29.6M | 4.89% |
394,300
-8,960
| -2% | -$745K |
|
4
Apple
AAPL
$4.54T
| $24.7M | 4.08% |
626,336
-11,336
| -2% | -$550K |
|
5
Walt Disney
DIS
$167B
| $22.9M | 3.79% |
209,025
-1,269
| -0.6% | -$144K |
|
6
Merck
MRK
$322B
| $20.2M | 3.33% |
276,874
-370
| -0.1% | -$26.1K |
|
7
Alphabet (Google) Class A
GOOGL
$4.36T
| $18M | 2.98% |
345,140
+280
| +0.1% | +$15.1K |
|
8
Meta Platforms (Facebook)
META
$1.42T
| $17.1M | 2.82% |
130,328
-261
| -0.2% | -$37.8K |
|
9
Intel
INTC
$455B
| $16.4M | 2.71% |
350,290
+1,929
| +0.6% | +$90.3K |
|
10
Chevron
CVX
$392B
| $15.4M | 2.54% |
141,163
-99
| -0.1% | -$11.5K |
|
11
Accenture
ACN
$102B
| $15.2M | 2.52% |
108,119
-1,255
| -1% | -$199K |
|
12
Coca-Cola
KO
$377B
| $14.8M | 2.45% |
312,732
+2,993
| +1% | +$143K |
|
13
JPMorgan Chase
JPM
$935B
| $14.8M | 2.44% |
151,110
+1,122
| +0.7% | +$120K |
|
14
IQVIA
IQV
$38.7B
| $14.5M | 2.39% |
124,720
-1,130
| -0.9% | -$137K |
|
15
iShares US Technology ETF
IYW
$23.6B
| $14.2M | 2.34% |
354,748
-9,796
| -3% | -$424K |
|
16
Johnson & Johnson
JNJ
$618B
| $13.7M | 2.27% |
106,510
+392
| +0.4% | +$54.7K |
|
|
RTN
17
DELISTED
Raytheon Company
RTN
| $13.2M | 2.17% |
85,813
-4,233
| -5% | -$758K |
|
18
iShares US Regional Banks ETF
IAT
$674M
| $13M | 2.15% |
327,250
-4,959
| -1% | -$225K |
|
19
Xylem
XYL
$27.3B
| $12.2M | 2.01% |
182,233
-1,150
| -0.6% | -$79.6K |
|
|
20
Visa
V
$684B
| $11.9M | 1.96% |
+89,818
| New | +$12.4M |
|
21
Thermo Fisher Scientific
TMO
$213B
| $11.6M | 1.92% |
52,026
-85
| -0.2% | -$19.9K |
|
22
FedEx
FDX
$72.7B
| $11.4M | 1.89% |
70,896
-584
| -0.8% | -$124K |
|
23
Intercontinental Exchange
ICE
$85.6B
| $11.1M | 1.84% |
147,765
-114
| -0.1% | -$8.74K |
|
24
Blackrock
BLK
$169B
| $11.1M | 1.84% |
28,318
+270
| +1% | +$111K |
|
25
AptarGroup
ATR
$8.55B
| $11M | 1.82% |
117,137
-460
| -0.4% | -$46.9K |
|
Similar funds
BII
HCM
LCM
DBC
SWM
DK
AVAX
IVA
Howard Capital Management (New York)'s Q4 2018 Portfolio in Review
As of Q4 2018, Howard Capital Management (New York) held 117 positions worth $606M, down 19% from $749M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Howard Capital Management (New York) withdrew a net $30.3M in Q4 2018, closing 9 positions and reducing 54 holdings. Its most notable exit was Express Scripts Holding Company, an estimated $493K position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Howard Capital Management (New York) opened a new position in Visa worth $11.9M.
- Howard Capital Management (New York)'s largest Q4 2018 buy was Visa: 89,818 shares worth $11.9M.
- Howard Capital Management (New York) added most to iShares US Medical Devices ETF in Q4 2018, an estimated $339K increase.
- Howard Capital Management (New York)'s biggest Q4 2018 reduction was SLB Ltd, cutting an estimated $8.23M.
- Howard Capital Management (New York) fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $493K.
- Howard Capital Management (New York)'s ten largest holdings make up 37% of its $606M portfolio in Q4 2018.
- Howard Capital Management (New York) opened 4 new positions and closed 9 in Q4 2018.
- Howard Capital Management (New York)'s portfolio value fell 19% quarter-over-quarter to $606M.
Based on Howard Capital Management (New York)'s 13F filing for Q4 2018, filed 17 Jan 2019.